ArticleCardiovascular diabetology. Endocrinology reports2026
Metabolic signatures and machine learning identify gut-liver-heart axis dysfunction as a potential link to major adverse cardiovascular events in coronary artery disease.
Article in Cardiovascular diabetology. Endocrinology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraditional risk factors do not fully account for the residual cardiometabolic risk of major adverse cardiovascular events (MACE) in coronary artery disease (CAD). We aimed to identify circulating metabolic signatures associated with MACE susceptibility and uncover potential pathobiological mechanisms underlying the gut-liver-heart axis.
methodsIn this retrospective case-control study, untargeted high-performance liquid chromatography-mass spectrometry (HPLC-MS) was performed on fasting serum from 200 patients with CAD and MACE, 200 with CAD without MACE, and 400 matched non-CAD controls. Metabolomics data were processed using univariate analysis, multivariate analysis, and eXtreme Gradient Boosting (XGBoost) machine learning. Pathway enrichment was conducted using metabolite set enrichment analysis. Circulating fibroblast growth factor 19 (FGF19) was quantified via enzyme-linked immunosorbent assay to validate enterohepatic endocrine disruption.
resultsThe MACE cohort exhibited a pronounced cardiometabolic phenotype, characterized by significantly highest rates of diabetes, hypertension, and dyslipidemia (p < 0.01). The XGBoost model robustly discriminated patients with CAD and MACE from non-CAD controls (area under the curve [AUC] = 0.984) and from patients with CAD without MACE (AUC = 0.932). Pathway analysis revealed marked dysregulation of linoleic acid metabolism and peroxisome proliferator-activated receptor (PPAR) signaling (p < 0.05). Specifically, pro-inflammatory oxidized linoleic acid metabolites, including 9- and 13-hydroxyoctadecadienoic acid (HODE)-which drive plaque instability-were significantly elevated in the MACE cohort. Furthermore, atheroprotective primary bile acids were significantly depleted in patients with CAD (p < 0.001). This depletion was accompanied by an elevated serum FGF19 level (p = 0.003), reflecting a potential disruption of the gut-liver-heart endocrine axis.
conclusionsIn conclusion, dysregulated linoleic acid oxidation, altered PPAR signaling, and disturbed primary bile acid-FGF19 metabolism may represent key metabolic pathways associated with MACE susceptibility. Integrating these gut-liver-heart axis signatures into machine learning models holds significant promise for refining cardiovascular risk stratification and guiding targeted preventive interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.